VaxCelerate II: Rapid development of a self-assembling vaccine for Lassa fever
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
VaxCelerate II: Rapid development of a self-assembling vaccine for Lassa fever
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 10, Issue 10, Pages 3022-3038
Publisher
Informa UK Limited
Online
2014-11-02
DOI
10.4161/hv.34413
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Robust Immunity to an Auxotrophic Mycobacterium bovis BCG-VLP Prime-Boost HIV Vaccine Candidate in a Nonhuman Primate Model
- (2013) G. K. Chege et al. JOURNAL OF VIROLOGY
- Yellow Fever Vaccination Elicits Broad Functional CD4+T Cell Responses That Recognize Structural and Nonstructural Proteins
- (2013) Eddie A. James et al. JOURNAL OF VIROLOGY
- An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity
- (2013) Juan C Zapata et al. Virology Journal
- The two-faced T cell epitope
- (2013) Leonard Moise et al. Human Vaccines & Immunotherapeutics
- Immunization with cross-conserved H1N1 influenza CD4+T-cell epitopes lowers viral burden in HLA DR3 transgenic mice
- (2013) Leonard Moise et al. Human Vaccines & Immunotherapeutics
- Vaccination Strategies against Highly Pathogenic Arenaviruses: The Next Steps toward Clinical Trials
- (2013) Stephan Ölschläger et al. PLoS Pathogens
- A Fusion Protein between Streptavidin and the Endogenous TLR4 Ligand EDA Targets Biotinylated Antigens to Dendritic Cells and Induces T Cell ResponsesIn Vivo
- (2013) Laura Arribillaga et al. Biomed Research International
- Differential MyD88/IRAK4 requirements for cross-priming and tumor rejection induced by heat shock protein 70-model antigen fusion protein
- (2012) Shusaku Mizukami et al. CANCER SCIENCE
- Mycobacterial and mouse HSP70 have immuno-modulatory effects on dendritic cells
- (2012) R. Spiering et al. CELL STRESS & CHAPERONES
- Magic bullets for the 21st century: the reemergence of immunotherapy for multi- and pan-resistant microbes
- (2012) D. Roux et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant
- (2012) Corinna La Rosa et al. JOURNAL OF INFECTIOUS DISEASES
- Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model
- (2012) Marco A. Goicochea et al. VACCINE
- Accelerated vaccine development against emerging infectious diseases
- (2012) Pierre R. Leblanc et al. Human Vaccines & Immunotherapeutics
- Primary Vaccination with Low Dose Live Dengue 1 Virus Generates a Proinflammatory, Multifunctional T Cell Response in Humans
- (2012) Janet C. Lindow et al. PLoS Neglected Tropical Diseases
- The anti-inflammatory mechanisms of Hsp70
- (2012) Thiago J. Borges et al. Frontiers in Immunology
- Generation of MHC class I ligands in the secretory and vesicular pathways
- (2011) Margarita Del Val et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Efficient Rescue of Recombinant Lassa Virus Reveals the Influence of S Segment Noncoding Regions on Virus Replication and Virulence
- (2011) C. G. Albarino et al. JOURNAL OF VIROLOGY
- Biodefence since 9/11: The price of protection
- (2011) Erika Check Hayden NATURE
- Pathogenesis of lassa fever in cynomolgus macaques
- (2011) Lisa E Hensley et al. Virology Journal
- Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses
- (2011) Rebecca J. Grant-Klein et al. VIRUS RESEARCH
- Involvement of CD91 and scavenger receptors in Hsp70-facilitated activation of human antigen-specific CD4+memory T cells
- (2010) Nadja Fischer et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A Multivalent Vaccination Strategy for the Prevention of Old World Arenavirus Infection in Humans
- (2010) J. Botten et al. JOURNAL OF VIROLOGY
- Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs
- (2010) Xiaohong Jiang et al. VACCINE
- Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
- (2010) Luis M Branco et al. Virology Journal
- Effect of Recombinant Heat Shock Protein 70 of Mycobacterial Origin on Cytotoxic Activity and Immunophenotype of Human Peripheral Blood Mononuclear Leukocytes
- (2009) D. S. Vorobiev et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Comparative Evaluation of the Immune Responses and Protection Engendered by LC16m8 and Dryvax Smallpox Vaccines in a Mouse Model
- (2009) C. A. Meseda et al. Clinical and Vaccine Immunology
- Reducing risk, improving outcomes: Bioengineering less immunogenic protein therapeutics
- (2009) Anne S. De Groot et al. CLINICAL IMMUNOLOGY
- Furin-Processed Antigens Targeted to the Secretory Route Elicit Functional TAP1-/-CD8+ T Lymphocytes In Vivo
- (2009) F. Medina et al. JOURNAL OF IMMUNOLOGY
- An N-Terminal Region of Lassa Virus L Protein Plays a Critical Role in Transcription but Not Replication of the Virus Genome
- (2009) M. Lelke et al. JOURNAL OF VIROLOGY
- In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes
- (2009) Leonard Moise et al. VACCINE
- A Multivalent and Cross-Protective Vaccine Strategy against Arenaviruses Associated with Human Disease
- (2009) Maya F. Kotturi et al. PLoS Pathogens
- Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates
- (2008) Igor S. Lukashevich et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started